Trending...
- 2023 Employee Handbook Templates Now Available
- Orbex Introduces Double Profits for New Traders
- It's about time to visit Morven Museum & Garden for "Striking Beauty: New Jersey Tall Case Clocks, 1730–1830"
QView's AI-QVCAD, combined with GEHC's ABUS breast ultrasound system, potentially accelerates the acceptance of 3D breast ultrasound as supplemental screening for women with dense breast tissue.
LOS ALTOS, Calif. - eTravelWire -- QView, Inc., a medical technology leader providing artificial intelligence systems for breast cancer detection, and GEHC have signed a distribution agreement where QView Medical's AI-QVCAD software system will be added to GEHC's portfolio of breast imaging AI solutions for the detection and diagnosis of breast cancer.
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on eTravel Wire
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on eTravel Wire
--
Under the definitive agreement, GEHC will market and sell AI-QVCAD for its ABUS – Automated Breast Ultrasound System.
"QView working with GEHC is an excellent example of two organizations leveraging our mutual strengths and technological capabilities to provide a multimodality approach for breast screening. There is no single imaging screening solution," said Bob Wang, President, and CEO of QView, Inc
Mammography misses one-third of the cancers in screening women with dense breast tissue; breast density increases women's cancer risk 4-6 times, affecting more than 40 percent of women1. Earlier cancer detection is critical to increased survival rates, improved patient care, and reduced cost of care.
More on eTravel Wire
- Local Real Estate Broker Offers Homeowners Cash Offer at Full Market Value with No Inspection Needed
- MaGO PR to Lead Specialized Public Relations Campaigns for the Presidio Trust
- Shima Capital's Founder Yida Gao Teaches Crypto Finance Course at MIT
- Max Amini Announces Powerful Interview with Reza Pahlavi, Former Crown Prince of Iran; to Premiere April 1st
- Trump Bus rolls into Georgia Ron DeSantis event overshadowing Tiny Desantis box truck at Veterans for Trump mini-rally ,Veterans For Trump aka VFAF
The ABUS 2.0 is the first FDA-approved Ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. Adding AI-QVCAD software to the ABUS system is a powerful tool in detecting breast cancers earlier when they are more treatable, less invasive treatments, and improve patient quality of life.
Clinicians can now review AI-QVCAD results on the Invenia ABUS Viewer, streamlining clinical workflow and reducing the reading time by up to 33%2 while improving clinical outcomes with up to 93%3 sensitivity for lesion detection.
QView Medical supports all efforts to raise awareness of breast density as a significant risk factor - #DENSEBREASTINFO #AREYOUDENSE. QView supports passage of #FINDITEARLY Federal bill requiring health insurers to reimburse for screening and diagnostic breast ultrasound exams – no copay, no deductible.
About QView Medical, Inc.
QView Medical develops AI image-analysis systems for 3D Automated Breast Ultrasound Systems ABUS). The QView team has been the leader in AI technologies and breast cancer detection for over twenty-five years, including developing R2 mammography CAD, R2 lung CT CAD, U-Systems ABUS, and QView AI QVCAD. Visit our website www.qviewmedical.com for more information.
More on eTravel Wire
- Palos Verdes Real Estate Agent Promotes Homes To MORE Opportune Buyers For Significantly MORE Money
- OnTheSnow visitors pick Steamboat as North America's 'Best Overall Ski Resort'
- Access Control Systems Expands and Rebrands as Guardian Access Solutions as Part of Increased Service Offerings
- Peachtree Immediate Care Opens Urgent Care Clinic in Marietta
- Olga Torres Named Top Advisor by Foreign Investment Watch
--
- Boyd, et al, NEJM Jan 2007
- Interpretation Time Using a Concurrent-Read Computer-Aided Detection System for Automated Breast Ultrasound in Breast Cancer Screening of Women with Dense Breast Tissue (Yulei Jiang). Read More: https://www.ajronline.org/doi/10.2214/AJR.18.19516
- Performance and Reading Time of Automated Breast US with or without Computer-aided Detection. Read More: https://pubs.rsna.org/doi/10.1148/radiol.2019181816
Source: Qview Medical, Inc.
0 Comments
Latest on eTravel Wire
- Genie Script: 20 Word Script by Wesley Virgin
- Jake Paul Teams Up with The Berman Team, Sponsored by Berman Law Group for charity event supporting Boxing Bullies
- Fulltale Outdoors Launches Eco Kayak Fishing Tour on Space Coast Near Orlando
- Dude Ranch Vacations at Historic O.T.O. Dude Ranch offer Excursions with Local Outfitters
- Matt Fogelgren to Join Cleartelligence Executive Team as Chief Revenue Officer
- Fun Facts About Utah's Desolation Canyon Rated One of America's Top Rafting Adventures
- Blue Harbor Resort Celebrates Global Meetings Industry Day
- Keebos Unveils Keebos 2.0: The Ultimate Crossbody Phone Case
- It's about time to visit Morven Museum & Garden for "Striking Beauty: New Jersey Tall Case Clocks, 1730–1830"
- Protecting and enhancing wildlife populations could be a global warming game changer
- Hai Robotics Wins Innovation Award for Existing Product at Promat 2023
- Our Local Tour announces its range of cultural tours in Ghana
- 2023 National Farmworker Awareness Week
- Orbex Introduces Double Profits for New Traders
- Quotehunt.co.uk: Revolutionising the UK B2B Market with Comprehensive Comparison Services for Small Businesses
- Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC , a partner of Veterans for Trump
- 2023 Employee Handbook Templates Now Available
- Mercy Street to Host the Largest Opening Day Event in the Organization's 20 Year History
- The Nashville International Chopin Piano Competition Announces the Alexei Sultanov Memorial Discovery Prize
- Kobie Voted a Top Workplace USA